Verghese E - Search Results

1

Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey.

Taniere P, Nicholson AG, Gosney JR, Montero Fernandez MA, Bury D, Moore DA, Verghese E, Soomro I, Joseph L, Bhatt N, Viola P, Bains R, Lanctot AG, Ryan J. Taniere P, et al. Among authors: verghese e. J Clin Pathol. 2024 Jun 19;77(7):486-494. doi: 10.1136/jcp-2023-208890. J Clin Pathol. 2024. PMID: 37258251 Free PMC article.

2

MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer.

Baxter DE, Allinson LM, Al Amri WS, Poulter JA, Pramanik A, Thorne JL, Verghese ET, Hughes TA. Baxter DE, et al. Among authors: verghese et. Cancers (Basel). 2021 Nov 28;13(23):5979. doi: 10.3390/cancers13235979. Cancers (Basel). 2021. PMID: 34885090 Free PMC article.

3

Meta-analysis of effect of vegetarian diet on ischemic heart disease and all-cause mortality.

Jabri A, Kumar A, Verghese E, Alameh A, Kumar A, Khan MS, Khan SU, Michos ED, Kapadia SR, Reed GW, Kalra A. Jabri A, et al. Among authors: verghese e. Am J Prev Cardiol. 2021 Apr 9;7:100182. doi: 10.1016/j.ajpc.2021.100182. eCollection 2021 Sep. Am J Prev Cardiol. 2021. PMID: 34611632 Free PMC article.

4

The variability in neurological deficits in Duchenne muscular dystrophy patients may be explained by differences in dystrophin glycoprotein complexes in the brain and muscle.

Verghese E. Verghese E. Neuroreport. 2021 Oct 13;32(15):1229-1233. doi: 10.1097/WNR.0000000000001710. Neuroreport. 2021. PMID: 34494993 Review.

5

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.

Gwili N, Jones SJ, Amri WA, Carr IM, Harris S, Hogan BV, Hughes WE, Kim B, Langlands FE, Millican-Slater RA, Pramanik A, Thorne JL, Verghese ET, Wells G, Hamza M, Younis L, El Deeb NMF, Hughes TA. Gwili N, et al. Among authors: verghese et. Br J Cancer. 2021 Sep;125(7):983-993. doi: 10.1038/s41416-021-01484-w. Epub 2021 Jul 12. Br J Cancer. 2021. PMID: 34253873 Free PMC article.

6

Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants.

Al Amri WS, Baxter DE, Hanby AM, Stead LF, Verghese ET, Thorne JL, Hughes TA. Al Amri WS, et al. Among authors: verghese et. Breast Cancer Res Treat. 2020 Oct;183(3):607-616. doi: 10.1007/s10549-020-05836-7. Epub 2020 Jul 30. Breast Cancer Res Treat. 2020. PMID: 32734521 Free PMC article.

7

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.

Verma R, Hanby AM, Horgan K, Verghese ET, Volpato M, Carter CR, Hughes TA. Verma R, et al. Among authors: verghese et. Breast Cancer Res Treat. 2020 Aug;183(1):49-59. doi: 10.1007/s10549-020-05757-5. Epub 2020 Jun 23. Breast Cancer Res Treat. 2020. PMID: 32577938 Free PMC article.

8

CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma.

Nair A, Ingram N, Verghese ET, Wijetunga I, Markham AF, Wyatt J, Prasad KR, Coletta PL. Nair A, et al. Among authors: verghese et. Cell Oncol (Dordr). 2020 Oct;43(5):835-845. doi: 10.1007/s13402-020-00530-8. Epub 2020 May 28. Cell Oncol (Dordr). 2020. PMID: 32468445 Free PMC article.

9

Digital pathology for primary diagnosis of screen-detected breast lesions - experimental data, validation and experience from four centres.

Williams B, Hanby A, Millican-Slater R, Verghese E, Nijhawan A, Wilson I, Besusparis J, Clark D, Snead D, Rakha E, Treanor D. Williams B, et al. Among authors: verghese e. Histopathology. 2020 Jun;76(7):968-975. doi: 10.1111/his.14079. Epub 2020 May 12. Histopathology. 2020. PMID: 31994224 Review.

10

Genomic and Expression Analyses Define MUC17 and PCNX1 as Predictors of Chemotherapy Response in Breast Cancer.

Al Amri WS, Allinson LM, Baxter DE, Bell SM, Hanby AM, Jones SJ, Shaaban AM, Stead LF, Verghese ET, Hughes TA. Al Amri WS, et al. Among authors: verghese et. Mol Cancer Ther. 2020 Mar;19(3):945-955. doi: 10.1158/1535-7163.MCT-19-0940. Epub 2019 Dec 26. Mol Cancer Ther. 2020. PMID: 31879365 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters